Nitrol and Effient drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrol (nitroglycerin) and Effient (prasugrel hydrochloride). Common drug interactions include viral infection among females and hypocalcaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrol and Effient. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrol?

Nitrol has active ingredients of nitroglycerin. eHealthMe is studying from 3,069 Nitrol users. Check the latest studies of Nitrol.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.



On Jul, 18, 2026

24 people who take Nitrol and Effient together, and have interactions are studied.

Nitrol and Effient drug interactions.

What are the common drug interactions of Nitrol and Effient, by gender? *:

female:

  1. Viral infection
  2. Abdominal discomfort
  3. Abdominal pain upper
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Fall
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Injection site bruising
  8. Injection site discolouration
  9. Injection site erythema (redness at injection site)
  10. Injection site pain

male:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  3. Duodenal ulcer
  4. Dyspnoea (difficult or laboured respiration)
  5. Gastric cancer stage iv (cancer cells have spread to distant organs)
  6. Gastritis (inflammation of stomach)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Neuralgia (pain in one or more nerves)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. White blood cell count increased

What are the common drug interactions of Nitrol and Effient, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Atrioventricular block (heart block)
  2. Chest pain
  3. Flushing (the warm, red condition of human skin)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Weight increased

50-59:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Fall
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Injection site bruising
  7. Injection site discolouration
  8. Injection site erythema (redness at injection site)
  9. Injection site pain
  10. Injection site pruritus (severe itching at injection site)

60+:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Abnormal dreams
  5. Aggression
  6. Anxiety
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Blood glucose increased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Cardiac disorder

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 41.67%
  2. Chest Pain: 10 people, 41.67%
  3. High Blood Cholesterol: 8 people, 33.33%
  4. Pain: 6 people, 25.00%
  5. Insomnia (sleeplessness): 5 people, 20.83%
  6. Diarrhea: 5 people, 20.83%
  7. Dyspnea (difficult or laboured breathing): 5 people, 20.83%
  8. Fever: 5 people, 20.83%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 20.83%
  10. Urinary Tract Infection: 5 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrol and Effient?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitrol and Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effient and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and prasugrel hydrochloride (the active ingredients of Nitrol and Effient, respectively), and Nitrol and Effient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: